Latest News

In recognition of her outstanding and innovative work as Program Director of the Movement Disorders Fellowship, Sara Schaefer, MD, MHS, has been honored with the American Academy of Neurology (AAN) 2025 Fellowship Program Director Recognition Award.

Using single-cell transcriptomics and proteomics, Yale researchers have created a detailed cell atlas of brains affected by Parkinson’s disease.

The new Yale center is the first to focus on developing precision medicine for Parkinson’s disease.

Associate Professor of Neurology Sule Tinaz, MD, PhD, is interviewed by Power Over Parkinson's on how high-intensity exercise can ease the symptoms of Parkinson's disease, slow progression of the disease, and improve quality of life.

Studies show that high-intensity exercise may slow the progression of the disease.

Congratulations to Sreeganga Chandra, INP Associate Professor of Neurology and Neuroscience, who was the recipients of the 2024 Graduate Mentor Award in Biological and Biomedical Sciences.

The Marcus Foundation has awarded $13.2 million to Yale School of Medicine, to support a clinical trial that could mark a first step toward a preventive treatment for Parkinson's disease.

Six months of high-intensity aerobic exercise preserves the dopamine-producing neurons in the brain, a small pilot study finds.

Associate Professor, Neurology; Clinical Chief, Movement Disorders; and Inaugural Director, Yale Comprehensive Parkinson Disease Care Center Veronica Santini, MD, MA, served as a panelist on a virtual conference for the American Parkinson Disease Association (APDA).